The role of SNPs in the α-chain of the IL-7R gene in CD4+ T-cell recovery in HIV-infected African patients receiving suppressive cART

Rajasuriar, R; Booth, D R; Gouillou, M; Spelman, T; James, I; Solomon, A; Chua, K; Stewart, G; Deeks, S; Bangsberg, D R; Muzoora, C; Cameron, P U; Hunt, P; Martin, J; Lewin, S R
January 2012
Genes & Immunity;Jan2012, Vol. 13 Issue 1, p83
Academic Journal
We previously found an association between faster CD4+ T-cell recovery in HIV-infected patients receiving combination antiretroviral therapy (cART) and interleukin-7 receptor-α (IL-7Rα) haplotype-2 in a predominantly Caucasian cohort. This study aims to determine whether this association was also significant in Africans. Patients were recruited from the Uganda AIDS Rural Treatment Outcomes (UARTO) cohort (n=352). We used survival analysis and linear mixed modelling (LMM) to determine factors associated with CD4 T-cell recovery. Eight IL-7Rα single-nucleotide polymorphisms (SNPs) were genotyped in both Africans and Caucasians (n=57). Soluble (s)IL-7Rα levels were measured by ELISA. In UARTO, IL-7Rα haplotype-2 was associated with slower CD4 T-cell recovery following cART by using survival analysis (P=0.020) and no association was found with LMM (P=0.958). The tagging-SNP for IL-7Rα haplotype-2 (rs6897932) was associated with decreased sIL-7Rα (P<0.001). The haplotypes for the IL-7Rα were significantly different in Africans and Caucasians. Using IL-7Rα genotypes we found slower CD4 T-cell recovery in UARTO patients was still associated with rs6897932 (P=0.009) and rs3194051 was associated with faster CD4 T-cell recovery (P=0.006). Unlike Caucasians, we did not demonstrate a significant association between IL-7Rα haplotype 2 and faster CD4 T-cell recovery in Africans. The IL-7Rα SNPs associated with CD4 T-cell recovery following cART differ in African and Caucasian cohorts.


Related Articles

  • Genetic polymorphisms of Fas (CD95) and Fas ligand (CD178) influence the rise in CD4+ T cell count after antiretroviral therapy in drug-naïve HIV-positive patients. Nasi, Milena; Pinti, Marcello; Bugarini, Roberto; Troiano, Leonarda; Lugli, Enrico; Bellodi, Cristian; Mussini, Cristina; Borghi, Vanni; Trenti, Tommaso; Balli, Fiorella; Esposito, Roberto; Cossarizza, Andrea // Immunogenetics;Oct2005, Vol. 57 Issue 9, p628 

    Fas and Fas ligand (FasL) are the main genes that control cell death in the immune system. Indeed, they are crucial for the regulation of T lymphocyte homeostasis because they can influence cell proliferation. A strong debate exists on the importance of Fas/FasL system during HIV infection,...

  • DermaVir: A Novel Topical Vaccine for HIV/AIDS. Lisziewicz, Julianna; Trocio, Jeffrey; Whitman, Lucia; Varga, Georg; Xu, Jianqing; Bakare, Nyasha; Erbacher, Patrick; Fox, Cecil; Woodward, Ruth; Markham, Phil; Arya, Suresh; Behr, Jean-Paul; Lori, Franco // Journal of Investigative Dermatology;Jan2005, Vol. 124 Issue 1, p160 

    Human immunodeficiency virus (HIV) vaccines have the potential to improve antiretroviral drug treatment by inducing cytotoxic killing of HIV-infected cells. Prophylactic vaccines utilize new antigens to initiate immunity; however, in HIV-infected individuals the load of viral antigen is not the...

  • Decay of the HIV Reservoir in Patients Receiving Antiretroviral Therapy for Extended Periods: Implications for Eradication of Virus. Tae-Wook Chun; Justement, J. Shawn; Moir, Susan; Hallahan, Claire W.; Maenza, Janine; Mullins, James I.; Collier, Ann C.; Corey, Lawrence; Fauci, Anthony S. // Journal of Infectious Diseases;6/15/2007, Vol. 195 Issue 12, p1762 

    The persistence of latently infected resting CD4+ T cells has been clearly demonstrated in human immunodeficiency virus (HIV)-infected individuals receiving effective antiviral therapy. However, estimates of the half-life of this viral reservoir have been quite divergent. We demonstrate clear...

  • Maintenance of HIV-Specific Memory B-Cell Responses in Elite Controllers Despite Low Viral Burdens. Buckner, Clarisa M.; Kardava, Lela; Xiaozhen Zhang; Gittens, Kathleen; Justement, J. Shawn; Kovacs, Colin; McDermott, Adrian B.; Yuxing Li; Sajadi, Mohammad M.; Tae-Wook Chun; Fauci, Anthony S.; Moir, Susan; Zhang, Xiaozhen; Li, Yuxing; Chun, Tae-Wook // Journal of Infectious Diseases;8/1/2016, Vol. 214 Issue 3, p390 

    Human immunodeficiency virus (HIV)-specific B-cell responses in infected individuals are maintained by active HIV replication. Suppression of viremia by antiretroviral therapy (ART) leads to quantitative and qualitative changes that remain unclear. Accordingly, B-cell responses were investigated...

  • Relationship between T Cell Activation and CD4+ T Cell Count in HIV-Seropositive Individuals with Undetectable Plasma HIV RNA Levels in the Absence of Therapy. Hunt, Peter W.; Brenchley, Jason; Sinclair, Elizabeth; McCune, Joseph M.; Roland, Michelle; Page-Shafer, Kimberly; Hsue, Priscilla; Emu, Brinda; Krone, Melissa; Lampiris, Harry; Douek, Daniel; Martin, Jeffrey N.; Deeks, Steven G. // Journal of Infectious Diseases;1/1/2008, Vol. 197 Issue 1, p126 

    Background. Although untreated human immunodeficiency virus (HIV)-infected patients maintaining undetectable plasma HIV RNA levels (elite controllers) have high HIV-specific immune responses, it is unclear whether they experience abnormal levels of T cell activation, potentially contributing to...

  • Enfuvirtide (T-20): A Novel Human Immunodeficiency Virus Type 1 Fusion Inhibitor. Cervia, Joseph S.; Smith, Miriam A. // Clinical Infectious Diseases;10/15/2003, Vol. 37 Issue 8, p1102 

    Describes the development of highly active antiretroviral therapy in reducing the progression of AIDS in HIV-infected patients in the U.S. Improvement of the life expectancy of patients; Conformational changes in the HIV envelope glycoprotein 41; Sensitivity of viral envelope to synthetic...

  • Optimizing Predictive Mining Techniques in HIV-Related Opportunistic Infections: Case for Botswana. Buthu'gwashe; Zhiyong Li; Kirui, Clement // International Journal of Computer Applications;Aug2013, Vol. 76 Issue 1-16, p1 

    Botswana was one of the first countries to establish a national Antiretroviral therapy (ART) programme in Africa. "Masa," a native word depicting "a new dawn," is the programme name. The AIDS epidemic has led to the emergence of several disease entities which in the pre-AIDS era seemed...

  • Free antiretroviral treatment effective in Malawi.  // Infectious Disease News;Jun2008, Vol. 21 Issue 6, p39 

    The article reports on the results of a study on the efficiency of antiretroviral therapy in Malawi. It revealed that mortality rates of patients with HIV and AIDS have been reduced following the introduction of free antiretroviral therapy. According to researchers, the mortality rate was 9.8...

  • Comparing antiretroviral treatment outcomes between a prospective community-based and hospital-based cohort of HIV patients in rural Uganda. Kipp, Walter; Konde-Lule, Joseph; Rubaale, Tom; Okech-Ojony, Joa; Alibhai, Arif; Saunders, Duncan L. // BMC International Health & Human Rights;2011 Supplement 2, Vol. 11 Issue Suppl 2, p1 

    Background: Improved availability of antiretroviral therapy in sub-Saharan Africa is intended to benefit all eligible HIV-infected patients; however in reality antiretroviral services are mainly offered in urban hospitals. Poor rural patients have difficulty accessing the drugs, making the...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics